Review: Antibodies to cutaneous human papillomaviruses

Journal of Medical Virology

Volumn 84, Issue 5, 2012, Pages 814-822

  Antonsson, Annika ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Antibodies; Cutaneous; Human papillomavirus; Risk factor; Seroprevalence

Indexed keywords

VIRUS ANTIBODY;

ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 1; HUMAN PAPILLOMAVIRUS TYPE 14; HUMAN PAPILLOMAVIRUS TYPE 38; HUMAN PAPILLOMAVIRUS TYPE 5; HUMAN PAPILLOMAVIRUS TYPE 60; HUMAN PAPILLOMAVIRUS TYPE 8; HUMAN PAPILLOMAVIRUS TYPE 88; HUMAN PAPILLOMAVIRUS TYPE 93; NONHUMAN; PAPILLOMAVIRUS INFECTION; REVIEW; RISK FACTOR; SEROLOGY; SEROPREVALENCE; VIRUS LIKE AGENT; WART VIRUS;

ANTIBODIES, VIRAL; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SKIN DISEASES, VIRAL; WARTS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 84858604402     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23257     Document Type: Review

References (68)

1. Andersson K, Waterboer T, Kirnbauer R, Slupetzky K, Iftner T, de Villiers EM, Forslund O, Pawlita M, Dillner J. 2008. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions. Cancer Epidemiol Biomarkers Prev 17: 189- 195.
2. Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG. 2000. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 74: 11636- 11641.
3. Antonsson A, Erfurt C, Hazard K, Holmgren V, Simon M, Kataoka A, Hossain S, Håkangård C, Hansson BG. 2003. Prevalence and type spectrum of human papillomaviruses in healthy skin samples collected in three continents. J Gen Virol 84: 1881- 1886.
4. Antonsson A, Green AC, Mallitt KA, O'Rourke PK, Pandeya N, Pawlita M, Waterboer T, Neale RE. 2010. Prevalence and stability of antibodies to 37 human papillomavirus types-A population-based longitudinal study. Virology 407: 26- 32.
5. Asgari MM, Kiviat NB, Critchlow CW, Stern JE, Argenyi ZB, Raugi GJ, Berg D, Odland PB, Hawes SE, de Villiers EM. 2008. Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J Invest Dermatol 128: 1409- 1417.
6. Barr BB, Benton EC, McLaren K, Bunney MH, Smith IW, Blessing K, Hunter JA. 1989. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1: 124- 129.
7. Berkhout RJ, Bouwes Bavinck, Ter JN, Schegget J. 2000. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 38: 2087- 2096.
8. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM. 2010. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401: 70- 79.
9. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, Eklund B, Fjeldborg O, Friedberg M, Frodin L, Glattre E, Halvorsen S, Holm NV, Jakobsen A, Jorgensen HE, Ladefoged J, Lindholm T, Lundgren G, Pukkala E. 1995. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 60: 183- 189.
10. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. 2009. A review of human carcinogens-Part B: Biological agents. Lancet Oncol 10: 321- 322.
11. Bouwes Bavinck JN, Stark S, Petridis AK, Marugg ME, Ter Schegget J, Westendorp RG, Fuchs PG, Vermeer BJ, Pfister H. 2000. The presence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated humanpapillomavirus type 8 in patients with actinic keratoses. Br J Dermatol 142: 103- 109.
12. Bouwes Bavinck JN, Neale RE, Abeni D, Euvrard S, Green AC, Harwood CA, de Koning MN, Naldi L, Nindl I, Pawlita M, Pfister H, Proby CM, Quint WG, ter Schegget J, Waterboer T, Weissenborn S, Feltkamp MC. 2010. Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res 70: 9777- 9786.
13. Caldeira S, Zehbe I, Accardi R, Malanchi I, Dong W, Giarre M, de Villiers EM, Filotico R, Boukamp P, Tommasino M. 2003. The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J Virol 77: 2195- 2206.
14. Casabonne D, Michael KM, Waterboer T, Pawlita M, Forslund O, Burk RD, Travis RC, Key TJ, Newton R. 2007. A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European prospective investigation into cancer and nutrition. Int J Cancer 121: 1862- 1868.
15. Casabonne D, Lally A, Mitchell L, Michael KM, Waterboer T, Pawlita M, Imko-Walczuk B, Wojnarowska F, Proby C, Harwood C, Newton R. 2009a. A case-control study of cutaneous squamous cell carcinoma among Caucasian organ transplant recipients: The role of antibodies against human papillomavirus and other risk factors. Int J Cancer 125: 1935- 1945.
16. Casabonne D, Waterboer T, Michael KM, Pawlita M, Lally A, Mitchell L, Imko-Walczuk B, Wojnarowska F, Newton R, Proby C, Harwood C. 2009b. The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK. Infect Agent Cancer 4: 13.
17. Casabonne D, Waterboer T, Michael KM, Pawlita M, Mitchell L, Newton R, Harwood C, Proby C. 2009c. The seroprevalence of human papillomavirus by immune status and by ethnicity in London. Infect Agent Cancer 4: 14.
18. Castellsague X, Munoz N. 2003. Chapter 3: Cofactors in human papillomavirus carcinogenesis-Role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31: 20- 28.
19. Chen SL, Tsao YP, Lee JW, Sheu WC, Liu YT. 1993. Characterization and analysis of human papillomaviruses of skin warts. Arch Dermatol Res 285: 460- 465.
20. Chen AC-H, McMillan NAJ, Antonsson A. 2008. Human papillomavirus type spectrum in normal skin of individuals with or without a history of frequent sun exposure. J Gen Virol 89: 2891- 2897.
21. Cheng G, Icenogle JP, Kirnbauer R, Hubbert NL, St Louis ME, Han C, Svare EI, Kjaer SK, Lowy DR, Schiller JT. 1995. Divergent human papillomavirus type 16 variants are serologically cross-reactive. J Infect Dis 172: 1584- 1587.
22. de Koning MN, Weissenborn SJ, Abeni D, Bouwes Bavinck JN, Euvrard S, Green AC, Harwood CA, Naldi L, Neale R, Nindl I, Proby CM, Quint WG, Sampogna F, ter Schegget J, Struijk L, Wieland U, Pfister HJ, Feltkamp MC. 2009. Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. J Gen Virol 90: 1611- 1621.
23. Deau MC, Favre M, Jablonska S, Rueda LA, Orth G. 1993. Genetic heterogeneity of oncogenic human papillomavirus type 5 (HPV5) and phylogeny of HPV5 variants associated with epidermodysplasia verruciformis. J Clin Microbiol 31: 2918- 2926.
24. Dillner J. 1999. The serological response to papillomaviruses. Semin Cancer Biol 9: 423- 430.
25. Feltkamp MC, Broer R, di Summa FM, Struijk L, van der Meijden E, Verlaan BP, Westendorp RG, ter Schegget J, Spaan WJ, Bouwes Bavinck JN. 2003. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res 63: 2695- 2700.
26. Feltkamp MC, de Koning MN, Bavinck JN, Ter Schegget J. 2008. Betapapillomaviruses: Innocent bystanders or causes of skin cancer. J Clin Virol 43: 353- 360.
27. Forslund O, Iftner T, Andersson K, Lindelof B, Hradil E, Nordin P, Stenquist B, Kirnbauer R, Dillner J, de Villiers EM. 2007. Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis 196: 876- 883.
28. Gottschling M, Goker M, Kohler A, Lehmann MD, Stockfleth E, Nindl I. 2009. Cutaneotropic human beta-/gamma-papillomaviruses are rarely shared between family members. J Invest Dermatol 129: 2427- 2434.
29. Handisurya A, Gambhira R, Schellenbacher C, Shafti-Keramat S, Forslund O, Favre M, Kirnbauer R. 2009. Serological relationship between cutaneous human papillomavirus types 5, 8 and 92. J Gen Virol 90: 136- 143.
30. Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, Breuer J, Proby CM. 2000. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 61: 289- 297.
31. Hazard K, Eliasson L, Dillner J, Forslund O. 2006. Subtype HPV38b[FA125] demonstrates heterogeneity of human papillomavirus type 38. Int J Cancer 119: 1073- 1077.
32. Hazard K, Andersson K, Dillner J, Forslund O. 2007a. Human papillomavirus subtypes are not uncommon. Virology 362: 6- 9.
33. Hazard K, Karlsson A, Andersson K, Ekberg H, Dillner J, Forslund O. 2007b. Cutaneous human papillomaviruses persist on healthy skin. J Invest Dermatol 127: 116- 119.
34. Iannacone MR, Michael KM, Giuliano AR, Waterboer T, Pawlita M, Rollison DE. 2010. Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida. J Infect Dis 201: 760- 769.
35. Jablonska S, Dabrowski J, Jakubowicz K. 1972. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res 32: 583- 589.
36. Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A, Green AC, Bavinck JN, Perry A, Spencer S, Rees JR, Mott LA, Pawlita M. 2006. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 98: 389- 395.
37. Karagas MR, Waterboer T, Li Z, Nelson HH, Michael KM, Bavinck JN, Perry AE, Spencer SK, Daling J, Green AC, Pawlita M. 2010. Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: Population based case-control study. BMJ 341: c2986.
38. Kilkenny M, Merlin K, Young R, Marks R. 1998. The prevalence of common skin conditions in Australian school students: 1. Common, plane and plantar viral warts. Br J Dermatol 138: 840- 845.
39. Kiviat NB. 1999. Papillomaviruses in non-melanoma skin cancer: Epidemiological aspects. Semin Cancer Biol 9: 397- 403.
40. Kohler A, Gottschling M, Manning K, Lehmann MD, Schulz E, Kruger-Corcoran D, Stockfleth E, Nindl I. 2011. Genomic characterization of ten novel cutaneous human papillomaviruses from keratotic lesions of immunosuppressed patients. J Gen Virol 92: 1585- 1594.
41. Kremsdorf D, Favre M, Jablonska S, Obalek S, Rueda LA, Lutzner MA, Blanchet-Bardon C, Van Voorst Vader PC, Orth G. 1984. Molecular cloning and characterization of the genomes of nine newly recognized human papillomavirus types associated with epidermodysplasia verruciformis. J Virol 52: 1013- 1018.
42. Kullander J, Handisurya A, Forslund O, Geusau A, Kirnbauer R, Dillner J. 2008. Cutaneous human papillomavirus 88: Remarkable differences in viral load. Int J Cancer 122: 477- 480.
43. Lally A, Casabonne D, Waterboer T, Imko-Walczuk B, Michael KM, Pawlita M, Newton R, Wojnarowska F. 2010. Association of seborrhoeic warts with skin cancer in renal transplant recipients. J Eur Acad Dermatol Venereol 24: 302- 307.
44. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. 2000. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 143: 513- 519.
45. Mallitt KA, O'Rourke P, Bouwes Bavinck JN, Abeni D, de Koning MN, Feltkamp MC, Green AC, Quint WG, Michael KM, Pawlita M, Pfister H, Weissenborn S, Waterboer T, Neale RE. 2010. An analysis of clustering of betapapillomavirus antibodies. J Gen Virol 91: 2062- 2067.
46. McIntyre-Seltman K, Castle PE, Guido R, Schiffman M, Wheeler CM. 2005. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev 14: 1165- 1170.
47. Michael KM, Waterboer T, Sehr P, Rother A, Reidel U, Boeing H, Bravo IG, Schlehofer J, Gartner BC, Pawlita M. 2008. Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog 4: e1000091.
48. Michael KM, Waterboer T, Pfister H, Gariglio M, Majewski S, Favre M, Pawlita M. 2009. Seroreactivity of 38 human papillomavirus types in epidermodysplasia verruciformis patients, relatives, and controls. J Invest Dermatol 130: 841- 848.
49. Oriel JD. 1971. Natural history of genital warts. Br J Vener Dis 47: 1- 13.
50. Orth G. 1987. Epidermodysplasia verruciformis. In: Salzman NP, Howley PM, editors. The Papovaviridae, the Papillomaviruses. New York: Plenum Press, pp 199- 243.
51. Paradisi A, Waterboer T, Sampogna F, Tabolli S, Simoni S, Pawlita ML, Abeni D. 2011. Seropositivity for human papillomavirus and incidence of subsequent squamous cell and basal cell carcinomas of the skin in patients with a previous non-melanoma skin cancer. Br J Dermatol 165: 782- 791.
52. Parkin DM. 2006. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118: 3030- 3044.
53. Plasmeijer EI, Neale RE, O'Rourke P, Mallitt KA, de Koning MN, Quint W, Buettner PG, Pawlita M, Waterboer T, Green AC, Feltkamp MC. 2010. Lack of association between the presence and persistence of betapapillomavirus DNA in eyebrow hairs and betapapillomavirus L1 antibodies in serum. J Gen Virol 91: 2073- 2079.
54. Proby CM, Harwood CA, Neale RE, Green AC, Euvrard S, Naldi L, Tessari G, Feltkamp MC, de Koning MN, Quint WG, Waterboer T, Pawlita M, Weissenborn S, Wieland U, Pfister H, Stockfleth E, Nindl I, Abeni D, Schegget JT, Bouwes Bavinck JN. 2011. A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant 11: 1498- 1508.
55. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. 2002. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32: 579- 581.
56. Sehr P, Zumbach K, Pawlita M. 2001. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: Validation for HPV serology. J Immunol Methods 253: 153- 162.
57. Stanley M. 2006. Immune responses to human papillomavirus. Vaccine 24: S16- S22.
58. Stanley MA. 2009. Immune responses to human papilloma viruses. Indian J Med Res 130: 266- 276.
59. Struijk L, Bouwes Bavinck, Wanningen JN, van der Meijden P, Westendorp E, Ter RG, Schegget J, Feltkamp MC. 2003. Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma. J Invest Dermatol 121: 1531- 1535.
60. Struijk L, Hall L, van der Meijden E, Wanningen P, Bavinck JN, Neale R, Green AC, Ter Schegget J, Feltkamp MC. 2006. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 15: 529- 535.
61. Struijk L, van der Meijden E, Kazem S, ter Schegget J, de Gruijl FR, Steenbergen RD, Feltkamp MC. 2008. Specific betapapillomaviruses associated with squamous cell carcinoma of the skin inhibit UVB-induced apoptosis of primary human keratinocytes. J Gen Virol 89: 2303- 2314.
62. Stubenrauch F, Laimins LA. 1999. Human papillomavirus life cycle: Active and latent phases. Semin Cancer Biol 9: 379- 386.
63. Termorshuizen F, Feltkamp MC, Struijk L, de Gruijl FR, Bavinck JN, van Loveren H. 2004. Sunlight exposure and (sero)prevalence of epidermodysplasia verruciformis-associated human papillomavirus. J Invest Dermatol 122: 1456- 1462.
64. Vasiljevic N, Hazard K, Eliasson L, Ly H, Hunziker A, de Villiers EM, Norrild B, Dillner J, Forslund O. 2007. Characterization of two novel cutaneous human papillomaviruses, HPV93 and HPV96. J Gen Virol 88: 1479- 1483.
65. Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, Templin MF, Pawlita M. 2005. Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 51: 1845- 1853.
66. Waterboer T, Abeni D, Sampogna F, Rother A, Masini C, Sehr P, Michael KM, Pawlita M. 2008. Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin. Br J Dermatol 159: 457- 459.
67. Waterboer T, Neale R, Michael KM, Sehr P, de Koning MN, Weissenborn SJ, Sampogna F, Abeni D, Green AC, Bouwes Bavinck JN, Pawlita M. 2009. Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. J Gen Virol 90: 1986- 1998.
68. Zur Hausen H. 2002. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2: 342- 350.